These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6664822)

  • 1. Synthesis, physical properties and microbiological activities of more water soluble silver sulfadiazine derivatives.
    De Wit PP; Van Doorne H; Bult A
    Pharm Weekbl Sci; 1983 Dec; 5(6):298-301. PubMed ID: 6664822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of in vitro sensitivity to sulfadiazine silver.
    McManus AT; Denton CL; Mason AD
    Arch Surg; 1983 Feb; 118(2):161-6. PubMed ID: 6401421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determination of the susceptibility of bacterial isolates to silver sulfadiazine.
    Rosenkranz HS; Carr HS
    Chemotherapy; 1978; 24(3):143-5. PubMed ID: 657875
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate.
    Saffer LD; Rodeheaver GT; Hiebert JM; Edlich RF
    Surg Gynecol Obstet; 1980 Aug; 151(2):232-6. PubMed ID: 6773164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new silver sulfadiazine water soluble gel.
    Gear AJ; Hellewell TB; Wright HR; Mazzarese PM; Arnold PB; Rodeheaver GT; Edlich RF
    Burns; 1997 Aug; 23(5):387-91. PubMed ID: 9426907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and antimicrobial activity of water-soluble silver(i) complexes of metronidazole drug and selected counter-ions.
    Kalinowska-Lis U; Felczak A; Chęcińska L; Zawadzka K; Patyna E; Lisowska K; Ochocki J
    Dalton Trans; 2015 May; 44(17):8178-89. PubMed ID: 25846722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility studies of silver sulfadiazine.
    Nesbitt RU; Sandmann BJ
    J Pharm Sci; 1977 Apr; 66(4):519-22. PubMed ID: 16113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of sulfadiazine compounds of zinc and silver.
    Nagesha CN
    Arch Surg; 1978 Jul; 113(7):906. PubMed ID: 678109
    [No Abstract]   [Full Text] [Related]  

  • 9. Zinc sulphadiazines: novel topical antimicrobial agents for burns.
    Lee AR; Huang WH
    J Pharm Pharmacol; 1995 Jun; 47(6):503-9. PubMed ID: 7674134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly water-dispersible silver sulfadiazine decorated with polyvinyl pyrrolidone and its antibacterial activities.
    Li P; Wu L; Li B; Zhao Y; Qu P
    Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():54-59. PubMed ID: 26706506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method to determine antibacterial activity of silver sulfadiazine creams.
    Klein S; Lentsch RH; Christoffersen G
    J Burn Care Rehabil; 1986; 7(5):382-4. PubMed ID: 3095328
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro inactivation of silver sulphadiazine by the addition of cerium salts.
    Holder IA
    Burns Incl Therm Inj; 1982 Mar; 8(4):274-7. PubMed ID: 7066726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility of silver sulfadiazine in physiological media and relevance to treatment of thermal burns with silver sulfadiazine cream.
    Tsipouras N; Rix CJ; Brady PH
    Clin Chem; 1995 Jan; 41(1):87-91. PubMed ID: 7813087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silver sulfadiazine: lack of mutagenic activity.
    McCoy EC; Rosenkranz HS
    Chemotherapy; 1978; 24(2):87-91. PubMed ID: 340170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release and antimicrobial activity of silver sulphadiazine from different creams.
    van Saene JJ; Trooster JF; Meulenhoff AM; Lerk CF
    Burns Incl Therm Inj; 1987 Apr; 13(2):123-30. PubMed ID: 3107761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of silver sulfadiazine 1% with chlorhexidine digluconate 0.2% to silver sulfadiazine 1% alone in the prophylactic topical antibacterial treatment of burns.
    Snelling CF; Inman RJ; Germann E; Boyle JC; Foley B; Kester DA; Fitzpatrick DJ; Warren RJ; Courtemanche AD
    J Burn Care Rehabil; 1991; 12(1):13-8. PubMed ID: 2022674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of cornstarch/cellulose acetate/silver sulfadiazine extrudate matrices.
    Zepon KM; Petronilho F; Soldi V; Salmoria GV; Kanis LA
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():225-33. PubMed ID: 25280700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing.
    Fraser JF; Bodman J; Sturgess R; Faoagali J; Kimble RM
    Burns; 2004 Feb; 30(1):35-41. PubMed ID: 14693084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver sulphadiazine: a comprehensive in vitro reassessment.
    Hamilton-Miller JM; Shah S; Smith C
    Chemotherapy; 1993; 39(6):405-9. PubMed ID: 8222868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.
    Hoffmann S
    Scand J Plast Reconstr Surg; 1984; 18(1):119-26. PubMed ID: 6377481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.